Stock News

FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
Gilead posts quarterly loss on acquisition charge, revenue rises 5%
US FDA mandates label updates on CAR-T cancer therapies
Gilead Sciences Publishes 2023 ESG Impact Report

As seen on...